UNSPSC 51413604: Cinepazet maleate

This classification denotes a vasodilating agent with the molecular formula C20H28N2O6.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F02NGQ0DSF, chemically known as 1-piperazineacetic acid, 4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, ethyl ester, (z)-2-butenedioate (1:1) but more generally known as cinepazet maleate, which bears US NIH Compound Identifier 6434394. Most nations, for tariff and trade purposes, schedule cinepazet maleate under HS 29335995 and SITC 51576.

As of Q4 2014, CINEPAZET MALEATE remains US FDA's Preferred Term for this commodity. SMILES: CCOC(=O)CN1CCN(CC1)C(=O)/C=C/C2CC(C(C(C2)OC)OC)OC.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51413604 Cinepazet maleate, a Commodity code, nominally designates a single pharmaceutical active ingredient but has generated little directly matching recent state and local procurement activity. The three opportunities recently posted under or near this code span a broader pharmaceutical and medical supply landscape: one targets emergency medications for fire rescue operations, one seeks information on direct-to-manufacturer prescription programs, and one establishes a cooperative purchasing vehicle for generic pharmaceuticals and OTC products across multiple states. The work being solicited reflects state and local demand for branded and generic pharmaceuticals, emergency medical supplies, and OTC products supplied through authorized wholesalers or direct manufacturer relationships, often with strict compliance requirements for expiration dates, manufacturing practices, FDA approvals, and supply-chain security.

Issuing bodies include city procurement offices (Tampa Fire Rescue's parent city), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon). Recent opportunities concentrate in Texas, Minnesota, Florida, and Oregon, with the MMCAP cooperative covering multi-state purchasing. The City of Tampa posted an Invitation for Bid (IFB) on April 24, 2026 (due April 8, 2026) for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with a nine-month minimum expiration window, estimated value $40,000, including a 5 percent SLBE bid discount. The Minnesota Department of Administration's Office of State Procurement issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through MMCAP, requiring manufacturers to supply through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, with pricing weighted at 75 percent and a two-year contract term. The Texas Health and Human Services Commission posted an RFI on March 27, 2026 (response due April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs serving self-insured employers and state agencies, representing exploratory procurement rather than a binding solicitation.